share_log

Analyst Expectations For BioLife Solns's Future

Analyst Expectations For BioLife Solns's Future

分析師對BioLife Solns未來的預期
Benzinga ·  11/18 21:00
BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
BioLife Solns (納斯達克股票代碼:BLFS)在過去三個月內得到4位分析師的分析評級,展示了從看好到看淡各種不同的觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Analysts have recently evaluated BioLife Solns and provided 12-month price targets. The average target is $29.75, accompanied by a high estimate of $32.00 and a low estimate of $27.00. Marking an increase of 2.59%, the current average surpasses the previous average price target of $29.00.
分析師最近對 BioLife Solns 進行了評估,並給出了 12 個月的目標價。平均目標價爲 $29.75,高估爲 $32.00,低估爲 $27.00。當前平均目標較之前的 $29.00 目標價提高了 2.59%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
The...
通...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論